AzTrials
AzTrials

Development, InfantNCT05767242

Early Neurophysiological Markers of Language Impairments

An observational study of Development, Infant and Development, Language, run by IRCCS Eugenio Medea at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. Read more about this study

Who is it for?
Ages 6 months to 8 yearsHealthy volunteers can take part
What is being tested?
Electrophysiological recording and Behavioral assessment
How many people
100 participants
Where
1 siteItaly
Study dates
21 Feb 2022to 31 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Healthy infants with and without familial risk for language impairments

Who may be able to join

  • Healthy infants aged <24 months
  • Infants with and without familial risk for language impairments (infants are assigned to the group with familial risk if at least one first-degree relative had a certified (clinical) diagnosis of language impairment or learning disability
  • Both parents are native-Italian speakers

Who cannot join

  • Gestational age < 37 weeks and/or birth weight < 2500 grams
  • APGAR scores at birth at 1' and 5' < 7
  • Bayley Cognitive Score < 7
  • Presence of certified diagnosis of intellectual deficiency, attention-deficit disorder, sensorial and neurological disorders, or autism within first-degree relative

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Italy1 site, 1 recruiting
  • Associazione La Nostra Famiglia - IRCCS Eugenio Medea

    Bosisio Parini, LC, 23842

    Chiara Cantiani, PhD, +39031877924, chiara.cantiani@lanostrafamiglia.it

    Recruiting

Other trials in Italy

About this study

Official title: Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk

The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.

Being tested
Electrophysiological recording, Behavioral assessment
Medical subject headings
Language, Language Development Disorders, Learning Disabilities

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Electrophysiological recordingOther

    Investigation of early neural markers using electrophysiology at 6-12-24 months

  • Behavioral assessmentBehavioural

    Individual behavioral assessment at later ages (3, 4.5, 6, and 8 years)

Study groups in NCT05767242
Study groupRoleWhat they receive
MEDEA BabyLab CohortNot described
Receives: Other: Electrophysiological recording; Behavioral: Behavioral assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Expressive vocabulary at age 3 years

    Standardized score in the Language Development Survey (Rescorla, 1989; Rescorla et al., 2014). Minimum=5; Maximum=95 (higher scores mean a better outcome).

    Measured: Age 3 years

  2. Phonological awareness at age 3 years

    Raw score in a syllabic blending task (created ad hoc). Scores are percentages of accuracy (higher scores mean a better outcome).

    Measured: Age 3 years

  3. Syntactic comprehension at age 3 years

    Standardized scores in the syntactic comprehension subtests, taken from 'Test for language evaluation', Cianchetti e Fancello, 1997. Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 3 years

  4. Lexical comprehension at age 3 years

    Raw score in the lexical comprehension subtest, taken from 'Battery for language evaluation in children 4-12 years', Marini et al., 2015. Scores are percentages of accuracy (higher scores mean a better outcome).

    Measured: Age 3 years

  5. Short-term verbal memory at age 4.5 years

    Standardized scores in the pseudo-word repetition subtest, taken from 'Battery for language evaluation in children 4-12 years', Marini et al., 2015. Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 4.5 years

  6. Phonological awareness at age 4.5 years

    Standardized scores in the phonological awareness subtests taken from 'Evaluation of phonological awareness skills', Marotta et al., 2008. Mean=10, Standard Deviation=3 (higher scores mean a better outcome).

    Measured: Age 4.5 years

  7. Phonological awareness at age 6 years

    Composite score of the standardized scores in the phonological awareness subtests (phoneme identification, phonemic segmentation), Cornoldi et al., 2009. Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 6 years

  8. Letter identification, knowledge, and writing at age 6 years

    Raw scores in the letter identification, knowledge, and writing subtests, taken from "Preschool Screening", Savelli et al., 2013. Minimum=0, Maximum=20 (higher scores mean a better outcome).

    Measured: Age 6 years

  9. Reading (accuracy, speed and comprehension) at age 8 years

    Standardized scores in the reading subtest, taken from 'Reading and comprehension assessment', Bonifacci et al., 2014. Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 8 years

  10. Spelling at age 8 years

    Standardized scores in the spelling task (Marinelli et al., 2016). Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 8 years

  11. Phonemic awareness at age 8 years

    Raw scores in the spoonerisms subtest taken from 'Evaluation of phonological awareness skills', Marotta et al., 2008. Minimum=0, Maximum=30 (higher scores mean a better outcome).

    Measured: Age 8 years

Secondary outcomes (5)
  1. Lexical access at age 4.5 years

    Standardized score in Rapid Automatic Naming. Mean=10, Standard Deviation=3 (higher scores mean a better outcome).

    Measured: Age 4.5 years

  2. Naming and articulatory accuracy at age 3 years

    Raw scores in the test of naming and articulatory accuracy (created ad hoc). Scores are percentages of accuracy (higher scores mean a better outcome).

    Measured: Age 3 years

  3. Nonverbal cognitive score at age 4.5 years

    Standardized score in the block design subtest, taken from 'Wechsler Preschool and Primary Scale of Intelligence, 3rd edition'. Mean=10, Standard Deviation=3 (higher scores mean a better outcome).

    Measured: Age 4.5 years

  4. Lexical access at age 6 years

    Standardized score in Rapid Automatic Naming, taken from Urgesi et al., 2011. Z-scores are calculated (higher scores mean a better outcome).

    Measured: Age 6 years

  5. Visual-motor integration at age 6 years

    Standardized score in the 'Developmental Test of Visual-Motor Integration', Preda, 2000. Minimum=5; Maximum=95 (higher scores mean a better outcome).

    Measured: Age 6 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Mar 2023
  2. Study start21 Feb 2022
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05767242
Sponsor's protocol ID
918
Status last verified
Feb 2025
First submitted
26 Jan 2023
Last updated
5 Feb 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Development, Infant and Development, Language, run by IRCCS Eugenio Medea at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chiara Cantiani, PhD (+39031877924, chiara.cantiani@lanostrafamiglia.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Expressive vocabulary at age 3 years (time frame: Age 3 years). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in